 |
|
|
| |
TENOFOVIR ALAFENAMIDE VERSUS TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B:
LIVER-RELATED CLINICAL OUTCOMES AND SUBGROUP ANALYSIS BY LIVER CIRRHOSIS STATUS
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
SS Kim*1, GH Seo*2, JE Han1, HJ Cho1, E Kim3, E Yoon4, ES Jang5, JI Chang3, YYoun Cho6, HW Lee7, JY Cheong1, and HJ Kim6
|
| |
|
|
|
|
|
